Suite Dreams

Most researchers would agree that manually performing a hundred or so plasmid preps after a low-efficiency cloning stifles the spirit of exploration that attracted them to science. Minipreps don't end with merely being tedious, repetitive, and time consuming--frequent exposure to hazardous chemicals adds to the misery. However, minipreps are a necessary evil in research, and the number of sequencing templates to prepare never seems to dwindle. For example, a small lab running four sequencing gel

Written byBob Sinclair
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Most researchers would agree that manually performing a hundred or so plasmid preps after a low-efficiency cloning stifles the spirit of exploration that attracted them to science. Minipreps don't end with merely being tedious, repetitive, and time consuming--frequent exposure to hazardous chemicals adds to the misery. However, minipreps are a necessary evil in research, and the number of sequencing templates to prepare never seems to dwindle. For example, a small lab running four sequencing gels a day with a 36-well comb can accommodate 144 samples a day; a larger operation running just one 96-capillary machine around the clock can analyze 1,000 templates daily. Preparing templates to meet this demand is challenging.

DNA purifications are not the only tedious and repetitive tasks associated with today's genomic world. The small lab in the above example, at 450 bases per read, will generate about 65 kb of raw sequencing data per day; the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies